<SEC-DOCUMENT>0001193125-19-044774-index.html : 20190220
<SEC-HEADER>0001193125-19-044774.hdr.sgml : 20190220
<ACCEPTANCE-DATETIME>20190220081532
ACCESSION NUMBER:		0001193125-19-044774
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20190219
ITEM INFORMATION:		Entry into a Material Definitive Agreement
FILED AS OF DATE:		20190220
DATE AS OF CHANGE:		20190220

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Allogene Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001737287
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				823562771
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38693
		FILM NUMBER:		19617139

	BUSINESS ADDRESS:	
		STREET 1:		210 EAST GRAND AVENUE
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		(650) 457-2700

	MAIL ADDRESS:	
		STREET 1:		210 EAST GRAND AVENUE
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d705652d8k.htm
<DESCRIPTION>8-K
<TEXT>
Document 1 - file: d705652d8k.htm

</DOCUMENT>
</SEC-DOCUMENT>